ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SOPH Sophia Genetics SA

4.64
0.00 (0.00%)
Pre Market
Last Updated: 09:01:35
Delayed by 15 minutes
Share Name Share Symbol Market Type
Sophia Genetics SA NASDAQ:SOPH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.64 4.10 7.00 0 09:01:35

SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference

22/02/2024 1:45pm

GlobeNewswire Inc.


Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart


From Feb 2024 to May 2024

Click Here for more Sophia Genetics Charts.

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Co-founder and Chief Executive Officer, Dr. Jurgi Camblong, and Chief Financial Officer and Chief Operating Officer, Ross Muken, will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference on Wednesday, March 6, 2024, at 10:30 a.m. EDT.

The fireside chat will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products, and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on X, LinkedIn, Facebook, and Instagram. Where others see data, we see answers. 

Investor Contact
Kellen Sanger
IR@sophiagenetics.com

Media Contact 
Kelly Katapodis
media@sophiagenetics.com

1 Year Sophia Genetics Chart

1 Year Sophia Genetics Chart

1 Month Sophia Genetics Chart

1 Month Sophia Genetics Chart

Your Recent History

Delayed Upgrade Clock